| Common Name | MDX-1333, MEDI-546, anifrolumab-fnia |
|---|---|
| Synonyms | IFN-R-1;CRF2-1;IFNAR |
| Applications | ELISA; Flow Cyt |
| Recommended Dilutions | ELISA 1:5000-10000; Flow Cyt 1:100 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Host Species | Homo sapiens |
| IgG type | IgG1 |
| Reactivity | Human |
| Target | |
| Uniprot ID | P17181 |
| Description | Anti-IFNAR1(anifrolumab biosimilar) mAb |
| Delivery | 2-3 weeks |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
Biotinylated Anti-IFNAR1(anifrolumab biosimilar) mAb
Price: 50μg $99.00 ; 100 μg $199.00